Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Crit Care Med ; 38(2): 596-601, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19851091

ABSTRACT

OBJECTIVE: To study angiotensin-converting enzyme 2 in a piglet model with acute respiratory distress syndrome and to evaluate the therapeutic potential of this substance in a preclinical setting, as this model allows the assessment of the same parameters required for monitoring the disease in human intensive care medicine. The acute respiratory distress syndrome is the most severe form of acute lung injury with a high mortality rate. As yet, there is no specific therapy for improving the clinical outcome. Recently, angiotensin-converting enzyme 2, which inactivates angiotensin II, has been shown to ameliorate acute lung injury in mice. DESIGN: Prospective, randomized, double-blinded animal study. SETTING: Animal research laboratory. SUBJECTS: Fifteen anesthetized and mechanically ventilated piglets. INTERVENTIONS: Acute respiratory distress syndrome was induced by lipopolysaccharide infusion. Thereafter, six animals were assigned randomly into angiotensin-converting enzyme 2 group, whereas another six animals served as control. Three animals received angiotensin-converting enzyme 2 without lipopolysaccharide pretreatment. MEASUREMENTS AND MAIN RESULTS: Systemic and pulmonary hemodynamics, blood gas exchange parameters, tumor necrosis factor-alpha, and angiotensin II levels were examined before acute respiratory distress syndrome induction and at various time points after administering angiotensin-converting enzyme 2 or saline. In addition, ventilation-perfusion distribution of the lung tissue was assessed by the multiple inert gas elimination technique. Animals treated with angiotensin-converting enzyme 2 maintained significantly higher PaO2 than the control group, and pulmonary hypertension was less pronounced. Furthermore, angiotensin II and tumor necrosis factor-alpha levels, both of which were substantially increased, returned to basal values. Multiple inert gas elimination technique revealed a more homogeneous pulmonary blood flow after treatment with angiotensin-converting enzyme 2. In intergroup comparisons, there were no differences in pulmonary blood flow to lung units with subnormal ventilation/perfusion ratios. CONCLUSIONS: Angiotensin-converting enzyme 2 attenuates arterial hypoxemia, pulmonary hypertension, and redistribution of pulmonary blood flow in a piglet model of acute respiratory distress syndrome, and may be a promising substance for clinical use.


Subject(s)
Peptidyl-Dipeptidase A/therapeutic use , Pulmonary Circulation/drug effects , Respiratory Distress Syndrome/drug therapy , Acute Lung Injury/drug therapy , Angiotensin-Converting Enzyme 2 , Animals , Blood Gas Analysis , Disease Models, Animal , Female , Heart Rate/drug effects , Hypertension, Pulmonary/drug therapy , Lipopolysaccharides/pharmacology , Male , Peptidyl-Dipeptidase A/blood , Recombinant Proteins/therapeutic use , Swine , Tumor Necrosis Factor-alpha/blood , Ventilation-Perfusion Ratio/drug effects
2.
Anesth Analg ; 106(5): 1566-71, table of contents, 2008 May.
Article in English | MEDLINE | ID: mdl-18420878

ABSTRACT

BACKGROUND: In a porcine model, we compared the effect of the combination of vasopressin/epinephrine with that of a lipid emulsion on survival after bupivacaine-induced cardiac arrest. METHODS: After administration of 5 mg/kg of a 0.5% bupivacaine solution i.v., ventilation was interrupted for 2 +/- 0.5 (mean +/- SD) min until asystole occurred. Cardiopulmonary resuscitation (CPR) was initiated after 1 min of untreated cardiac arrest. After 2 min of CPR, 10 animals received, every 5 min, either vasopressin combined with epinephrine or 4 mL/kg of a 20% lipid emulsion. Three minutes after each drug administration, up to three countershocks (4, 4, and 6 J/kg) were administered; all subsequent shocks with 6 J/kg. Blood for determination of the plasma bupivacaine concentration was drawn throughout the experiment. RESULTS: In the vasopressor group, all five pigs survived, whereas none of five pigs in the lipid group had restoration of spontaneous circulation (P < 0.01). There was no significant difference between groups in the plasma concentration of total bupivacaine. CONCLUSION: In this model of a bupivacaine-induced cardiac arrest, the vasopressor combination of vasopressin and epinephrine compared with lipid emulsion resulted in higher coronary perfusion pressure during CPR and survival rates.


Subject(s)
Asphyxia/complications , Epinephrine/pharmacology , Fat Emulsions, Intravenous/pharmacology , Heart Arrest/therapy , Vasoconstrictor Agents/pharmacology , Vasopressins/pharmacology , Anesthetics, Local/administration & dosage , Anesthetics, Local/blood , Animals , Asphyxia/blood , Asphyxia/drug therapy , Asphyxia/physiopathology , Asphyxia/therapy , Bupivacaine/administration & dosage , Bupivacaine/blood , Cardiopulmonary Resuscitation , Coronary Circulation/drug effects , Disease Models, Animal , Electric Countershock , Epinephrine/therapeutic use , Fat Emulsions, Intravenous/therapeutic use , Female , Heart Arrest/blood , Heart Arrest/drug therapy , Heart Arrest/etiology , Heart Arrest/physiopathology , Hemodynamics/drug effects , Injections, Intravenous , Male , Swine , Time Factors , Vasoconstrictor Agents/therapeutic use , Vasopressins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...